Pages that link to "Q34107054"
Jump to navigation
Jump to search
The following pages link to Integrin activation controls metastasis in human breast cancer (Q34107054):
Displaying 50 items.
- KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression (Q24305208) (← links)
- Interaction between circulating cancer cells and platelets: clinical implication (Q26778920) (← links)
- Platelets, coagulation and fibrinolysis in breast cancer progression (Q26823716) (← links)
- αV integrins in angiogenesis and cancer (Q26851768) (← links)
- Disintegrins from snake venoms and their applications in cancer research and therapy (Q27000037) (← links)
- Targeted nanotechnology for cancer imaging (Q27010317) (← links)
- The structure of Rap1 in complex with RIAM reveals specificity determinants and recruitment mechanism (Q27680703) (← links)
- The phosphotyrosine binding-like domain of talin activates integrins (Q28212748) (← links)
- Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis (Q28770073) (← links)
- Integrins in cancer: biological implications and therapeutic opportunities (Q29614536) (← links)
- RSK2 protein suppresses integrin activation and fibronectin matrix assembly and promotes cell migration (Q30423242) (← links)
- Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy (Q30437441) (← links)
- The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis (Q30441368) (← links)
- Molecular mechanisms and treatment of bone metastasis (Q30445717) (← links)
- The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. (Q30499283) (← links)
- Integrin-mediated cell surface recruitment of autotaxin promotes persistent directional cell migration (Q30566362) (← links)
- Activated tumor cell integrin αvβ3 cooperates with platelets to promote extravasation and metastasis from the blood stream (Q30764156) (← links)
- Quantitative Analysis of Platelet αvβ3 Binding to Osteopontin Using Laser Tweezers (Q33193773) (← links)
- A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer (Q33265964) (← links)
- Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureus (Q33281521) (← links)
- Review of continuing education course on hemostasis (Q33393140) (← links)
- Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond (Q33432917) (← links)
- Transcriptional regulation of the IGF signaling pathway by amino acids and insulin-like growth factors during myogenesis in Atlantic salmon (Q33608667) (← links)
- Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities (Q33654192) (← links)
- Platelet and osteoclast β 3 integrins are critical for bone metastasis (Q33715937) (← links)
- Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling (Q33754805) (← links)
- Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies (Q33805406) (← links)
- Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion (Q33892041) (← links)
- Breast cancer cell adhesome and degradome interact to drive metastasis (Q33914711) (← links)
- Mesenchymal migration as a therapeutic target in glioblastoma (Q34002994) (← links)
- Interstitial guidance of cancer invasion (Q34029050) (← links)
- Integrin αvβ3 drives slug activation and stemness in the pregnant and neoplastic mammary gland (Q34102993) (← links)
- Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1. (Q34119653) (← links)
- Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. (Q34134316) (← links)
- Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases (Q34154425) (← links)
- Platelets and cancer: a casual or causal relationship: revisited. (Q34294719) (← links)
- The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis (Q34365807) (← links)
- MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression (Q34372477) (← links)
- Brain metastases: biology and the role of the brain microenvironment. (Q34397760) (← links)
- Integrins and bone metastasis: integrating tumor cell and stromal cell interactions (Q34441622) (← links)
- The primacy of β1 integrin activation in the metastatic cascade (Q34441668) (← links)
- Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone (Q34508348) (← links)
- Adhesive and migratory effects of phosphophoryn are modulated by flanking peptides of the integrin binding motif (Q34513400) (← links)
- CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis (Q34534040) (← links)
- FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues (Q34556242) (← links)
- Understanding the role of keratins 8 and 18 in neoplastic potential of breast cancer derived cell lines (Q34558476) (← links)
- Synthesis and evaluation of new iRGD peptide analogs for tumor optical imaging (Q34572049) (← links)
- Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer (Q34616118) (← links)
- A novel tumor suppressor function of Kindlin-3 in solid cancer. (Q34619189) (← links)
- Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors. (Q34689304) (← links)